Bank of Montreal
CUE icon

Bank of Montreal’s Cue Biopharma CUE Stock Holding History

Bank of Montreal’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,130
Closed -$98K – 3858
2022
Q4 		$98K Buy
+1,130
New +$103K ﹤0.01% 3370
2021
Q2 		– Sell
-48
Closed -$18K – 3949
2021
Q1 		$18K Sell
48
-124
-72% -$51K ﹤0.01% 4098
2020
Q4 		$66K Buy
172
+108
+169% +$43.2K ﹤0.01% 3803
2020
Q3 		$30K Sell
64
-29
-31% -$16.7K ﹤0.01% 3637
2020
Q2 		$63K Buy
93
+76
+447% +$55.1K ﹤0.01% 3313
2020
Q1 		$7K Sell
17
-86
-83% -$41.7K ﹤0.01% 3591
2019
Q4 		$49K Buy
103
+25
+32% +$7.85K ﹤0.01% 3847
2019
Q3 		$19K Buy
78
+5
+7% +$1.2K ﹤0.01% 4119
2019
Q2 		$20K Buy
73
+52
+248% +$12.9K ﹤0.01% 4173
2019
Q1 		$5K Sell
21
-8
-28% -$1.52K ﹤0.01% 4023
2018
Q4 		$4K Buy
29
+25
+625% +$4.54K ﹤0.01% 4147
2018
Q3 		$1K Hold
4
– – ﹤0.01% 4507
2018
Q2 		$1K Buy
+4
New +$1.59K ﹤0.01% 4508

Other funds holding CUE

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's CUE Position: Q1 2023 in Review

Bank of Montreal sold out of Cue Biopharma (CUE) in Q1 2023, closing a stake of 1,130 shares — an estimated $98K sold.

Bank of Montreal first reported a position in CUE in Q2 2018 and held it in 13 quarters. The position peaked at $98K in Q4 2022. 63 funds tracked by Wall St. Rank hold CUE as of Q1 2023.

  • Bank of Montreal reported no remaining Cue Biopharma position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 1,130 Cue Biopharma shares in Q1 2023, an estimated $98K.
  • Bank of Montreal first reported a position in Cue Biopharma in Q2 2018 and held it in 13 quarters.
  • Bank of Montreal's Cue Biopharma position peaked at $98K in Q4 2022.
  • 63 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.